Starts 3 March 2027

3 to 4 March 2027

ImmunoMark London 2027 · ImmunoMark Summit London 2027: Immuno-Oncology & Biomarker Summit

London, United Kingdom · In person

Convolign Business Consulting

Register on the event site (opens in a new tab)
  • 2days
  • In personevent
  • Bookingopen, as stated by immunomarksummit.com
  • £399cheapest ticket, as stated by immunomarksummit.com

Verification trail

Where each detail came from

From another source

  • VenueLondon, UK, Englandread 27 Oct 2026
  • Catering and accessTwo parallel streams, networking lunches, Drinks and Cocktail Reception on Day 1.read 27 Oct 2026
  • RegistrationOpenread 27 Oct 2026
  • Fees£2,499 / delegate standard rate; £499 / delegate standard rate; £399 / delegate standard rate read 27 Oct 2026
  • Fee currencyGBPread 27 Oct 2026
  • Programme08:00 Registration and Networking Breakfast 08:45 Welcome Note by Chairperson Welcome Note by Chairperson 09:00 Keynote: The Future of Immuno-Oncology, Beyond Checkpoint Inhibitors Keynote: Biomarkers as the Foundation of Precision Immunotherapy 09:45 Engineering Advanced Cell and Gene Therapies for Solid Tumours Next-Generation Biomarker Platforms: Liquid Biopsy and Multi-Omics 10:30 Morning Refreshment Break (45 Minutes) 11:15 Overcoming Resistance Mechanisms and Tumour Microenvironment Challenges Biomarker Validation Strategies for Clinical Trial Success 12:00 AI-Driven Drug Discovery and Translational Acceleration in IO Companion Diagnostics Development: From Discovery to Regulatory Approval 13:00 Networking Lunch 14:00 Clinical Trial Design in Immunotherapy: Adaptive and Biomarker-Driven Models Digital Pathology and Spatial Transcriptomics in Oncology 14:45 Panel: Scaling Immunotherapies from Discovery to Commercialisation Panel: Regulatory Harmonisation for Biomarker Qualification 15:15 Evening Refreshment Break (45 Minutes) 16:00 Translating Early IO Science into Phase II Success Machine Learning Applications in Predictive Biomarker Modelling 16:45 The Next Decade of Immuno-Oncology Innovation The Future of Biomarker-Driven Oncology 17:30 Drinks and Cocktail Reception: Day 1 Networking 08:00 Registration and Morning Coffee 08:45 Chairperson Opening Remarks Chairperson Opening Remarks 09:00 Next-Generation Combination Immunotherapies Emerging Predictive and Prognostic Biomarkers in IO 09:45 Manufacturing and Scale-Up Challenges for Advanced Therapies Real-World Evidence Integration into Biomarker Strategy 11:15 Precision Safety Management and Risk Mitigation in IO Companion Diagnostics Commercialisation and Reimbursement Strategy 12:00 Translational Research: Bridging Academia and Industry Multiplex and Programmable Biomarker Platformsread 27 Oct 2026

Nothing recorded yet

  • Cancellation policyNot stated yet
  • AccreditationNot stated yet
  • Accrediting bodyNot stated yet
  • Credit typeNot stated yet
  • Credit hoursNot stated yet
  • Country of accreditationNot stated yet

Sources we read

Changes

  1. 27 Oct 2026Published was set to 27 Oct 2026
  2. 27 Oct 2026Programme was set to 08:00 Registration and Networking Breakfast 08:45 Welcome Note by Chairperson Welcome Note by Chairperson 09:00 Keynote: The Future of Immuno-Oncology, Beyond Checkpoint Inhibitors Keynote: Biomarkers as the Foundation of Precision Immunotherapy 09:45 Engineering Advanced Cell and Gene Therapies for Solid Tumours Next-Generation Biomarker Platforms: Liquid Biopsy and Multi-Omics 10:30 Morning Refreshment Break (45 Minutes) 11:15 Overcoming Resistance Mechanisms and Tumour Microenvironment Challenges Biomarker Validation Strategies for Clinical Trial Success 12:00 AI-Driven Drug Discovery and Translational Acceleration in IO Companion Diagnostics Development: From Discovery to Regulatory Approval 13:00 Networking Lunch 14:00 Clinical Trial Design in Immunotherapy: Adaptive and Biomarker-Driven Models Digital Pathology and Spatial Transcriptomics in Oncology 14:45 Panel: Scaling Immunotherapies from Discovery to Commercialisation Panel: Regulatory Harmonisation for Biomarker Qualification 15:15 Evening Refreshment Break (45 Minutes) 16:00 Translating Early IO Science into Phase II Success Machine Learning Applications in Predictive Biomarker Modelling 16:45 The Next Decade of Immuno-Oncology Innovation The Future of Biomarker-Driven Oncology 17:30 Drinks and Cocktail Reception: Day 1 Networking 08:00 Registration and Morning Coffee 08:45 Chairperson Opening Remarks Chairperson Opening Remarks 09:00 Next-Generation Combination Immunotherapies Emerging Predictive and Prognostic Biomarkers in IO 09:45 Manufacturing and Scale-Up Challenges for Advanced Therapies Real-World Evidence Integration into Biomarker Strategy 11:15 Precision Safety Management and Risk Mitigation in IO Companion Diagnostics Commercialisation and Reimbursement Strategy 12:00 Translational Research: Bridging Academia and Industry Multiplex and Programmable Biomarker Platforms
  3. 27 Oct 2026Fee currency was set to GBP
  4. 27 Oct 2026Registration was set to Open
  5. 27 Oct 2026Fees was set to £2,499 / delegate standard rate; £499 / delegate standard rate; £399 / delegate standard rate
  6. 27 Oct 2026Venue was set to London, UK, England
  7. 27 Oct 2026Catering and access was set to Two parallel streams, networking lunches, Drinks and Cocktail Reception on Day 1.

Spotted something wrong?

Tell us which detail looks off and we will check it against the source. We read every report and reply to each one.

Do you run this event? Claim this listing to keep its details right. Claiming gives you editing rights and no mark of approval.

May we count visits and load Google sign-in?

No advertising, nothing sold, and nothing is on until you choose. What we store · Privacy